These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28442245)

  • 1. Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjects.
    Sasamoto K; Hirayama S; Kon M; Seino U; Ueno T; Nagao Y; Hirayama A; Isshiki M; Idei M; Yano K; Miida T
    Clin Chim Acta; 2017 Jul; 470():56-63. PubMed ID: 28442245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE.
    Krimbou L; Tremblay M; Davignon J; Cohn JS
    J Lipid Res; 1997 Jan; 38(1):35-48. PubMed ID: 9034198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro factors affecting the concentration of gamma-LpE (gamma-LpE) in human plasma.
    Krimbou L; Tremblay M; Jacques H; Davignon J; Cohn JS
    J Lipid Res; 1998 Apr; 39(4):861-72. PubMed ID: 9555949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
    Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles.
    Krimbou L; Marcil M; Chiba H; Genest J
    J Lipid Res; 2003 May; 44(5):884-92. PubMed ID: 12611904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-step homogeneous assay for apolipoprotein E-containing high-density lipoprotein-cholesterol.
    Takahashi Y; Ito Y; Sakurai T; Wada N; Nagasaka A; Fujikawa M; Chiba H; Hui SP
    Ann Clin Biochem; 2019 Jan; 56(1):123-132. PubMed ID: 30068214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of the HDL-C and LDL-C direct methods and the subsequent evolution].
    Sugiuchi H; Matsushima K; Akiyoshi Y; Maeda K; Ando Y
    Rinsho Byori; 2012 Jul; 60(7):632-6. PubMed ID: 22973722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of homogeneous assay for simultaneous measurement of apoE-deficient, apoE-containing, and total HDL-cholesterol.
    Takahashi Y; Ito Y; Wada N; Nagasaka A; Fujikawa M; Sakurai T; Shrestha R; Hui SP; Chiba H
    Clin Chim Acta; 2016 Feb; 454():135-42. PubMed ID: 26776838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.
    Ballantyne CM; Miller M; Niesor EJ; Burgess T; Kallend D; Stein EA
    Am Heart J; 2012 Mar; 163(3):515-21, 521.e1-3. PubMed ID: 22424025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on apoE gene polymorphism and subclasses of serum high density lipoprotein in type IV hyperlipidemia].
    Tian Y; Long SY; Xu YH; Fu MD; Zhang XM; Liu BW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):96-8. PubMed ID: 15696494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study.
    Qi Y; Liu J; Wang W; Wang M; Zhao F; Sun J; Liu J; Zhao D
    J Clin Lipidol; 2018; 12(1):89-98.e2. PubMed ID: 29217413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.
    Talayero B; Wang L; Furtado J; Carey VJ; Bray GA; Sacks FM
    J Lipid Res; 2014 Oct; 55(10):2167-77. PubMed ID: 24966274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II.
    Hannuksela ML; Brousseau ME; Meyn SM; Nazih H; Bader G; Shamburek RD; Alaupovic P; Brewer HB
    Atherosclerosis; 2002 Dec; 165(2):205-20. PubMed ID: 12417271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.
    Huang Y; von Eckardstein A; Wu S; Assmann G
    J Clin Invest; 1995 Dec; 96(6):2693-701. PubMed ID: 8675636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T13M mutation of lecithin-cholesterol acyltransferase gene causes fish-eye disease.
    Miida T; Zhang B; Obayashi K; Seino U; Zhu Y; Ito T; Nakamura Y; Okada M; Saku K
    Clin Chim Acta; 2004 May; 343(1-2):201-8. PubMed ID: 15115696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and precise method for measuring plasma apoE-rich HDL using polyethylene glycol and cation-exchange chromatography: a pilot study on the clinical significance of apoE-rich HDL measurements.
    Ikeda T; Shinohata R; Murakami M; Hina K; Kamikawa S; Hirohata S; Kusachi S; Tamura A; Usui S
    Clin Chim Acta; 2017 Feb; 465():112-118. PubMed ID: 27993510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of unopposed conjugated equine estrogen on lipoprotein composition and apolipoprotein-E distribution.
    Muesing RA; Miller VT; LaRosa JC; Stoy DB; Phillips EA
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1250-4. PubMed ID: 1430085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.
    Kypreos KE; Zannis VI
    Biochem J; 2007 Apr; 403(2):359-67. PubMed ID: 17206937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL Particle Measurement: Comparison of 5 Methods.
    Matera R; Horvath KV; Nair H; Schaefer EJ; Asztalos BF
    Clin Chem; 2018 Mar; 64(3):492-500. PubMed ID: 29203475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.